Emerging Markets Regulatory Tracker: India (Vol. 5 No. 1)
This article was originally published in PharmAsia News
India has named members to expert committees on clinical trials and product approvals as well as announced new changes to clinical trials and GMP policies.
You may also be interested in...
India’s health ministry has laid out basic steps towards an overhaul of drug regulation at the local level, identifying a number of areas of concern.
China has released the results of back on proposed standards for the accreditation of clinical trial committees, investigators and sites.
China has finalized revised rules for the classification of medical devices, which will come into effect from the start of next year.